表紙
市場調查報告書
商品編碼
1017162

軟組織同類移植的全球市場

Soft Tissue Allografts: Global Markets

出版日期: | 出版商: BCC Research | 英文 149 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球軟組織異體移植片的市場規模在預測期間內預計以5.3%的年複合成長率發展,從2021年的51億美元,成長到2026年66億美元的規模。

各產品中,軟骨的部門同期間中預計以5.7%的年複合成長率發展,從2021年的15億美元,成長到2026年19億美元的規模。還有羊膜的部門以6.0%發展,從2021年的5億6510萬美元,成長到2026年7億5770萬美元的規模。

本報告提供全球軟組織異體移植片的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場、技術的背景,法律規章、償付環境,市場規模的變化、預測,產品、用途、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 摘要、亮點

第3章 市場、技術的背景

  • 軟組織同類移植
  • 關節痛、相關障礙:概要
  • 骨關節炎
  • 類風濕性關節炎
  • 創傷護理
  • 器官移植的選項
  • 軟組織同類移植技術與其替代法趨勢
  • 3D組織集合
  • 組織再生的奈米技術
  • 中小企業的革新

第4章 市場動態

  • 成長推動因素
  • 阻礙成長要素
  • 市場機會

第5章 市場分析、預測:各產品

  • 軟骨異體移植片
  • 肌腱異體移植片
  • 凸凹透鏡異體移植片
  • 牙科異體移植片
  • 膠原蛋白異體移植片
  • 羊膜異體移植片

第6章 市場分析、預測:各用途

  • 整形外科
  • 牙科
  • 創傷護理
  • 其他

第7章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 COVID-19的影響

第9章 法規、償付

第10章 競爭情形

  • 主要企業的市場佔有率
  • M&A
  • 主要的展開

第11章 企業簡介

  • ALLOSOURCE INC.
  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BIOHORIZONS IPH
  • BIOTISSUE TECHNOLOGIES GMBH
  • COOK MEDICAL INC.
  • GLOBUS MEDICAL INC.
  • INTEGRA LIFESCIENCES CORP.
  • JOHNSON & JOHNSON
  • MIMEDX GROUP INC.
  • ORGANOGENESIS INC.
  • SEASPINE
  • STRAUMANN HOLDING AG.
  • ZIMMER BIOMET HOLDINGS

第12章 附錄:縮寫

目錄
Product Code: BIO217A

Highlights:

The global market for soft tissue allografts should grow from $5.1 billion in 2021 to $6.6 billion by 2026, at compound annual growth rate (CAGR) of 5.3% for the period of 2021-2026.

Cartilage for soft tissue allografts should grow from $1.5 billion in 2021 to $1.9 billion by 2026, at a CAGR of 5.7% for the period of 2021-2026.

Amniotic for soft tissue allografts should grow from $565.1 million in 2021 to $757.7 million by 2026, at a CAGR of 6.0% for the period of 2021-2026.

Report Scope

The report will provide details about the soft tissue allografts used in the treatment of dental disease, facial dental surgery, orthopedic surgery, and other surgical processes. It will also highlight the current and future market potentiality of soft tissue allografts with detailed analysis of the competitive environment. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence dental diseases, orthopedic surgeries using allografts, and the regulatory scenario assessment will be covered in the report. The report includes a market projection for 2026, and a market share analysis for key players.

This report segments the market for soft tissue allografts based on products, applications, and geography. Product types are cartilage allografts, tendon allografts, meniscus allografts, dental allografts, collagen allografts, and amniotic allografts. Applications are orthopedic, dentistry, wound care, and others.

By geographical region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries, and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast value for 2026.

Tooth loss is very common and can happen as a result of disease or trauma, and the use of dental implants to provide support for the replacement of missing teeth has a long and multifaceted history. Statistics by the American Association of Oral and Maxillofacial Surgeons show that 69% of adults ages 35 to 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal, or tooth decay. Furthermore, by age 74, 26% of adults have lost all of their permanent teeth. Research on dental implant designs, materials and techniques has increased in the past few years and is expected to expand in the future due to the recent growth of the market for dental implants and the rise in demand for cosmetic dentistry, which points to increased demand for soft tissue allografts.

The increase in life expectancy and oral hygiene concerns have increased total dental visits; and additionally, the aging population plays a pivotal role in driving the demand for soft tissue allografts.

The report also includes a discussion of the major drivers and global dynamics, along with the political, economic, social, and technological factors that will have an impact on the market. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.

Report Includes:

  • 31 data tables and 22 additional tables
  • An updated review and in-depth analysis of the global market for soft tissue allografts
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Estimation of current market size and revenue forecast for global soft tissue allografts market, and corresponding market share analysis by product type, application and geography
  • Highlights of current and future market potential for soft tissue allografts with clinical applications in the treatment of dental disease, facial dental surgery, orthopedic surgery, and other surgical process
  • Discussion of market dynamics, industry structure, pricing analysis, prevalence or incidence dental diseases, regulatory scenario, and penetration of technologies within the biotech industry
  • Coverage of country specific data and analysis for the U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Brazil, Argentina, China, Japan, India, Australia, GCC countries and South Africa within the regional segment
  • Impact analysis of COVID-19 pandemic on the growth of this market
  • Review of patents issued for tissue allograft products and therapies, new developments and potential markets for future developments
  • Discussion of market regulations and reimbursement policies for transplant procedures within/outside the U.S., and treatment in the EU countries
  • Insight into the growth development strategies of the major players operating within the global market and their key competitive landscape
  • Profile descriptions of the leading industry players, including Anika Therapeutics Inc., Cook Medical Inc., Johnson & Johnson, Straumann Holding AG, and Zimmer Biomet Holdings

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Soft Tissue Allografts
  • General Overview of Joint Pain and Related Disorders
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Wound Care
  • Organ Transplantation Alternatives
  • Trends in Soft Tissue Allografts Techniques and Their Alternatives
  • 3D Tissue Assembly
  • Nanotechnology for Tissue Regeneration
  • Innovation by Small Firms

Chapter 4 Market Dynamics

  • Market Drivers
  • Increase in the Incidence of Chronic Diseases
  • Rise in the Geriatric Population
  • Rising Awareness of Importance of Soft Tissues in Sport Injuries
  • New Therapeutic Pathways for Organ Transplantation and Their Alternatives
  • Market Restraints
  • Challenges in Government Approval Process for Orthopedic Devices
  • Soft Tissue Graft Lower Outcome Challenges
  • Market Opportunities
  • Growing Economic Benefits of Organ and Tissue Transplants
  • Increasing Demand for Cosmetic Dentistry

Chapter 5 Market Breakdown by Product

  • Orthopedic Alternatives
  • Global Market for Soft Tissue Allografts
  • Cartilage Allografts
  • Market Size and Forecast
  • Tendon Allografts
  • Market Size and Forecast
  • Meniscus Allografts
  • Market Size and Forecast
  • Dental Allografts
  • Market Size and Forecast
  • Collagen Allografts
  • Market Size and Forecast
  • Market Size and Forecast
  • Amniotic Allografts

Chapter 6 Market Breakdown by Application

  • Global Market for Soft Tissue Allografts
  • Orthopedic Applications
  • Market Size and Forecast
  • Dentistry
  • Market Size and Forecast
  • Wound Care
  • Market Size and Forecast
  • Other Applications
  • Market Size and Forecast

Chapter 7 Market Breakdown by Region

  • Global Market for Soft Tissue Allografts by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia and New Zealand
  • Rest of Asia-Pacific
  • Latin America
  • Market Analysis
  • Brazil
  • Argentina
  • Rest of Latin American Countries
  • Middle East & Africa
  • Market Analysis
  • GCC Countries
  • South Africa
  • Rest of Middle Eastern & African Countries

Chapter 8 Impact of COVID-19

  • Introduction
  • Impact on Wound Care and Telehealth Management Program
  • Impact on Kidney Transplant Program
  • Donor Testing
  • COVID-19 in Transplant Recipients
  • Minimizing Infection Risk in Recipients
  • Future Perspectives

Chapter 9 Regulations and Reimbursement

  • Regulations in the U.S.
  • U.S. Federal Regulation of Human Tissue
  • History of Regulation in the U.S.
  • Regulations Outside the U.S.
  • Reimbursement in the U.S.
  • Organ Acquisition Costs
  • Reimbursement for Hospital Costs
  • Reimbursement for Physician Services
  • Reimbursement Outside the U.S.
  • Treatment in EU Countries

Chapter 10 Competitive Landscape

  • Market Share Analysis of Major Players
  • Mergers and Acquisitions
  • Key Developments
  • Mergers and Acquisitions in 2016-2018

Chapter 11 Company Profiles

  • ALLOSOURCE INC.
  • ANIKA THERAPEUTICS INC.
  • ARTHREX INC.
  • BIOHORIZONS IPH
  • BIOTISSUE TECHNOLOGIES GMBH
  • COOK MEDICAL INC.
  • GLOBUS MEDICAL INC.
  • INTEGRA LIFESCIENCES CORP.
  • JOHNSON & JOHNSON
  • MIMEDX GROUP INC.
  • ORGANOGENESIS INC.
  • SEASPINE
  • STRAUMANN HOLDING AG.
  • ZIMMER BIOMET HOLDINGS

Chapter 12 Appendix: Acronyms

List of Tables

  • Summary Table : Global Market for Soft Tissue Allografts, by Product, Through 2026
  • Table 1 : Cost of Hard-To-Heal Wounds
  • Table 2 : MiMedx: Patent Portfolio
  • Table 3 : Selected Global Commercial Opportunities for New Orthopedic Devices in the Future
  • Table 4 : Indications for Bioartificial Liver Transplantation
  • Table 5 : Global Market for Soft Tissue Allografts, by Product, Through 2026
  • Table 6 : Cartilage and Soft Tissue Biologics and Biomaterials
  • Table 7 : Global Market for Cartilage Allografts, by Region, Through 2026
  • Table 8 : Global Market for Tendon Allografts, by Region, Through 2026
  • Table 9 : Global Market for Meniscus Allografts, by Region, Through 2026
  • Table 10 : Global Market for Dental Allografts, by Region, Through 2026
  • Table 11 : Global Market for Collagen Allografts, by Region, Through 2026
  • Table 12 : Global Market for Amniotic Allografts, by Region, Through 2026
  • Table 13 : Global Market for Soft Tissue Allografts, by Application, Through 2026
  • Table 14 : Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, Through 2026
  • Table 15 : Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, Through 2026
  • Table 16 : Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, Through 2026
  • Table 17 : Global Market for Other Applications in the Soft Tissue Allografts, by Region, Through 2026
  • Table 18 : Global Market for Soft Tissue Allografts, by Region, Through 2026
  • Table 19 : North American Market for Soft Tissue Allografts, by Product, Through 2026
  • Table 20 : North American Market for Soft Tissue Allografts, by Application, Through 2026
  • Table 21 : North American Market for Soft Tissue Allografts, by Country, Through 2026
  • Table 22 : European Market for Soft Tissue Allografts, by Product, Through 2026
  • Table 23 : European Market for Soft Tissue Allografts, by Application, Through 2026
  • Table 24 : European Market for Soft Tissue Allografts, by Country, Through 2026
  • Table 25 : Examples of the Cost of Bone Damage Repair and Related Disorders in Europe
  • Table 26 : Asia-Pacific Market for Soft Tissue Allografts, by Product, Through 2026
  • Table 27 : Asia-Pacific Market for Soft Tissue Allografts, by Application, Through 2026
  • Table 28 : Asia-Pacific Market for Soft Tissue Allografts, by Country, Through 2026
  • Table 29 : Joint Replacement Procedures in Australia, 2017
  • Table 30 : Latin American Market for Soft Tissue Allografts, by Product, Through 2026
  • Table 31 : Latin American Market for Soft Tissue Allografts, by Application, Through 2026
  • Table 32 : Latin American Market for Soft Tissue Allografts, by Country, Through 2026
  • Table 33 : Middle Eastern & African Market for Soft Tissue Allografts, by Product, Through 2026
  • Table 34 : Middle Eastern & African Market for Soft Tissue Allografts, by Application, Through 2026
  • Table 35 : Registered Liver Transplantations (LT)/Kidney Transplantation in Middle East Countries, 2017
  • Table 36 : Middle Eastern & African Market for Soft Tissue Allografts, by Country, Through 2026
  • Table 37 : Number of Organ Transplant Procedures in Turkey, by Type of Organ, 2019-2020
  • Table 38 : Selected Transplant Industry Acquisitions, 2010-2020
  • Table 39 : AlloSource Inc.: Product Portfolio
  • Table 40 : Anika Therapeutics Inc.: Product Portfolio
  • Table 41 : BioHorizons: Products
  • Table 42 : Cook Medical Inc.: Product Portfolio
  • Table 43 : Globus Medical Inc.: Product Portfolio
  • Table 44 : Integra: Product Portfolio
  • Table 45 : Johnson & Johnson: Product Portfolio
  • Table 46 : MiMedx Group Inc.: Product Portfolio
  • Table 47 : Organogenesis Inc.: Product Portfolio
  • Table 48 : SeaSpine: Product Portfolio
  • Table 49 : Straumann Holding AG: Product Portfolio
  • Table 50 : Zimmer Biomet Holdings: Product Portfolio
  • Table 51 : Zimmer Biomet Holdings: Products
  • Table 52 : Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market Shares of Soft Tissue Allografts, by Product, 2020
  • Figure 1 : Nanotechnology and Tissue Regeneration
  • Figure 2 : Number of Elderly (≥ 65 Years) Receiving Kidney Transplantation in the U.S., 2014-2018
  • Figure 3 : Number of Diabetes Patients Globally (20 to 79 Years of Age), 2000-2045
  • Figure 4 : Percentage Distribution of Population Aged 65 and Above, by Region, 2015 and 2050
  • Figure 5 : Number of Kidney Transplants, by Country, 2015
  • Figure 6 : Patients on Waiting List vs. Transplants Performed in the U.S., by Organ, 2019
  • Figure 7 : Global Market Shares of Soft Tissue Allografts, by Product, 2020
  • Figure 8 : Global Market for Cartilage Allografts, 2019-2026
  • Figure 9 : Global Market for Cartilage Allografts, by Region, 2019-2026
  • Figure 10 : Global Market for Tendon Allografts, 2019-2026
  • Figure 11 : Global Market for Tendon Allografts, by Region, 2019-2026
  • Figure 12 : Global Market for Meniscus Allografts, 2019-2026
  • Figure 13 : Global Market for Meniscus Allografts, by Region, 2019-2026
  • Figure 14 : Global Market for Dental Allografts, 2019-2026
  • Figure 15 : Number of People Affected, by Common Dental Diseases, 2010
  • Figure 16 : Global Market for Dental Allografts, by Region, 2019-2026
  • Figure 17 : Global Market for Collagen Allografts, 2019-2026
  • Figure 18 : Global Market for Collagen Allografts, by Region, 2019-2026
  • Figure 19 : Percentages of Type III Collagen Found in Mammalian Dermis
  • Figure 20 : Global Market for Amniotic Allografts, 2019-2026
  • Figure 21 : Global Market for Amniotic Allografts, by Region, 2019-2026
  • Figure 22 : Global Market Shares of Soft Tissue Allografts, by Application, 2020
  • Figure 23 : Global Market for Orthopedic Applications in Soft Tissue Allografts, 2019-2026
  • Figure 24 : Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, 2019-2026
  • Figure 25 : Global Market for Dentistry Applications in Soft Tissue Allografts, 2019-2026
  • Figure 26 : Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, 2019-2026
  • Figure 27 : Global Market for Wound Care Applications in Soft Tissue Allografts, 2019-2026
  • Figure 28 : Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, 2019-2026
  • Figure 29 : Global Market for Other Applications in Soft Tissue Allografts, 2019-2026
  • Figure 30 : Global Market for Other Applications in Soft Tissue Allografts, by Region, 2019-2026
  • Figure 31 : Global Market Shares of Soft Tissue Allografts, by Region, 2020
  • Figure 32 : North American Market Shares of Soft Tissue Allografts, by Product, 2020
  • Figure 33 : North American Market Shares of Soft Tissue Allografts, by Application, 2020
  • Figure 34 : North American Market Shares for Soft Tissue Allografts, by Country, 2020
  • Figure 35 : United States' Market for Soft Tissue Allografts, 2019-2026
  • Figure 36 : Canadian Market for Soft Tissue Allografts, 2019-2026
  • Figure 37 : Mexican Market for Soft Tissue Allografts, 2019-2026
  • Figure 38 : European Market Shares of Soft Tissue Allografts, by Product, 2020
  • Figure 39 : European Market Shares of Soft Tissue Allografts, by Application, 2020
  • Figure 40 : European Market Shares of Soft Tissue Allografts, by Country, 2020
  • Figure 41 : German Market for Soft Tissue Allografts, 2019-2026
  • Figure 42 : French Market for Soft Tissue Allografts, 2019-2026
  • Figure 43 : U.K. Market for Soft Tissue Allografts, 2019-2026
  • Figure 44 : Italian Market for Soft Tissue Allografts, 2019-2026
  • Figure 45 : Spanish Market for Soft Tissue Allografts, 2019-2026
  • Figure 46 : Rest of Europe's Market for Soft Tissue Allografts, 2019-2026
  • Figure 47 : Asia-Pacific Market Shares of Soft Tissue Allografts, by Product, 2020
  • Figure 48 : Asia-Pacific Market Shares of Soft Tissue Allografts, by Application, 2020
  • Figure 49 : Asia-Pacific Market Shares for Soft Tissue Allografts, by Country, 2020
  • Figure 50 : Japanese Market for Soft Tissue Allografts, 2019-2026
  • Figure 51 : Chinese Market for Soft Tissue Allografts, 2019-2026
  • Figure 52 : Indian Market for Soft Tissue Allografts, 2019-2026
  • Figure 53 : Australia and New Zealand's Market for Soft Tissue Allografts, 2019-2026
  • Figure 54 : Rest of Asia-Pacific Market for Soft Tissue Allografts, 2019-2026
  • Figure 55 : Latin American Market Shares for Soft Tissue Allografts, by Product, 2020
  • Figure 56 : Latin American Market Shares for Soft Tissue Allografts, by Application, 2020
  • Figure 57 : Latin American Market Shares for Soft Tissue Allografts and Alternatives, by Country, 2020
  • Figure 58 : Brazilian Market for Soft Tissue Allografts, 2019-2026
  • Figure 59 : Argentinian Market for Soft Tissue Allografts, 2019-2026
  • Figure 60 : Rest of Latin American Countries Market for Soft Tissue Allografts, 2019-2026
  • Figure 61 : Middle Eastern & African Market Shares for Soft Tissue Allografts, by Product, 2020
  • Figure 62 : Middle Eastern & African Market Shares for Soft Tissue Allografts, by Application, 2020
  • Figure 63 : Middle Eastern & African Market Shares for Soft Tissue Allografts, by Country, 2020
  • Figure 64 : GCC Countries Market for Soft Tissue Allografts, 2019-2026
  • Figure 65 : South African Market for Soft Tissue Allografts, 2019-2026
  • Figure 66 : Rest of Middle Eastern & African Countries Market for Soft Tissue Allografts, 2019-2026
  • Figure 67 : Steep Reduction in Organ & Tissue Transplantation Seen During COVID-19
  • Figure 68 : Market Shares of Major Players in the Soft Tissue Allograft, 2020
  • Figure 69 : AlloSource Inc.: Annual Revenue, 2018-2020
  • Figure 70 : Anika Therapeutics Inc.: Annual Revenue, 2016-2020
  • Figure 71 : Anika Therapeutics Inc.: Revenue Shares, by Region/Country, 2020
  • Figure 72 : Anika Therapeutics Inc.: Revenue Shares, by Business Unit, 2020
  • Figure 73 : Johnson & Johnson: Annual Revenue, 2016-2020
  • Figure 74 : Johnson & Johnson: Revenue Shares, by Region/Country, 2019
  • Figure 75 : Johnson & Johnson: Revenue Shares, by Business Unit, 2019
  • Figure 76 : Organogenesis Inc.: Annual Revenue, 2017-2020
  • Figure 77 : Organogenesis Inc.: Revenue Shares by Products, 2020
  • Figure 78 : Straumann Holding AG: Annual Revenue, 2017-2020
  • Figure 79 : Straumann Holding AG: Revenue Shares, by Region/Country, 2020
  • Figure 80 : Zimmer Biomet Holdings: Annual Revenue, 2016-2020
  • Figure 81 : Zimmer Biomet Holdings: Revenue Shares, by Region, 2020
  • Figure 82 : Zimmer Biomet Holdings: Revenue Shares, by Products, 2020